Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
ore-1001 (1 trial)
Colitis (Phase 2)
Colitis, Ulcerative (Phase 2)
Ulcer (Phase 2)
Trials (1 total)
Trial APIs (1 total)